Oxytocin
Oxytocin is an endogenous nonapeptide hormone and FDA-approved injectable medicine (Pitocin) that acts on the oxytocin receptor to stimulate uterine contraction and is also widely studied for central roles in social behavior.
Oxytocin is a nine-amino-acid (nonapeptide) hormone produced in the hypothalamus and released from the posterior pituitary. Its structure is a cyclic peptide: the residues Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, in which the two cysteines (positions 1 and 6) form an intramolecular disulfide bridge and the C-terminus is amidated, giving a six-residue ring with a three-residue tail. It is structurally very close to the antidiuretic hormone vasopressin, differing at only two of the nine positions, which accounts for oxytocin's residual pressor and antidiuretic activity at high doses.
Oxytocin acts through the oxytocin receptor (OXTR), a Gq-coupled G-protein-coupled receptor. In the myometrium and mammary tissue, receptor activation increases intracellular calcium via the phospholipase C / IP3 pathway, driving uterine contraction and milk ejection. Myometrial receptor density rises markedly during pregnancy and peaks in early labor, so the uterine response to a given dose is highly individualized.
As a medicine, synthetic oxytocin is an FDA-approved prescription product (Pitocin, Syntocinon) given intravenously or intramuscularly under medical supervision for induction or augmentation of labor where there is a medical indication, and to control postpartum bleeding or hemorrhage. The FDA label notes that the product is not indicated for elective induction of labor. Important safety considerations include uterine hyperstimulation and rupture with excessive dosing, and water intoxication/hyponatremia from the molecule's antidiuretic activity when large fluid volumes are infused.
Beyond obstetrics, oxytocin is one of the most widely studied neuropeptides for central roles in social cognition, trust, pair-bonding, and stress regulation, frequently administered intranasally in research settings. These uses are investigational and not FDA-approved; rigorous randomized trials, including the NEJM SOARS-B study in autism spectrum disorder, have produced largely mixed-to-negative results, and intranasal formulations remain unstandardized. This entry is informational only and is not a recommendation for human use.
Oxytocin is an agonist at the oxytocin receptor (OXTR), a Gq-coupled G-protein-coupled receptor; in uterine and mammary smooth muscle, receptor activation drives phospholipase C, IP3 generation, and a rise in intracellular calcium, producing rhythmic contractions and milk ejection. The same receptor system is expressed in brain regions implicated in social bonding and stress regulation, which underlies its widely studied central neuropeptide roles.
- Human evidence
- High for licensed obstetric use; preliminary/mixed for behavioral research
- Regulatory status
- FDA-approved prescription medicine as injectable oxytocin (Pitocin, Syntocinon) for labor induction/augmentation and control of postpartum hemorrhage; administered IV/IM under medical supervision. Intranasal and other behavioral/"research" uses are NOT FDA-approved and remain investigational.
- Studied as a uterotonic agent and in obstetric pharmacology research on labor and postpartum hemorrhage.
- Investigated in neuroscience research on social cognition, trust, pair-bonding, and stress regulation, often via intranasal administration.
- Examined in randomized controlled trials for social functioning in autism spectrum disorder, with mostly inconclusive or negative outcomes.
- Used as a tool compound to probe oxytocin-receptor (OXTR) signaling and its overlap with the vasopressin system.
- The FDA label for injectable oxytocin (Pitocin) states it is not indicated for elective induction of labor; misuse can cause uterine hyperstimulation, tetanic contractions, and uterine rupture (FDA Pitocin label).
- High doses or prolonged IV infusion with large fluid volumes can cause water intoxication / hyponatremia due to the molecule's inherent antidiuretic activity (FDA label; StatPearls).
- Reported adverse effects include hypotension, tachycardia/arrhythmia, nausea, and fetal heart-rate changes; clinical use requires monitoring (DrugBank; StatPearls).
- Investigational intranasal products are unapproved and unstandardized; controlled trials in autism social cognition have yielded largely mixed-to-negative results (NEJM SOARS-B trial; additional RCTs).
- [1]PubChem Compound 439302: OxytocinPubChem
- [2]Oxytocin — DrugBank (DB00107)DrugBank
- [3]Oxytocin — StatPearls, NCBI BookshelfNCBI Bookshelf / StatPearls
- [4]Pitocin (oxytocin injection, USP) FDA prescribing informationFDA